Company: CHD
Filing Date: 2025-02-13
Form Type: 10-K
Source: 0000950170-25-019801
Chunk: 89

Company: CHURCH & DWIGHT CO INC /DE/
Filing Date: 2025-02-13
Form: 10-K
Item: Item 1B
Chunk 89
---
    5.7
    %

    Pricing/Product mix
     
    3.3
    %

    Foreign exchange rate fluctuations
     
    (0.2
    %)

    Acquired product lines (1)
     
    1.0
    %

    Net Sales increase
     
    9.8
    %

(1)The Graphico acquisition is included in our results since June 3, 2024, the date of acquisition.

Excluding the impact of foreign exchange rates and the Graphico acquisition, the increase in net sales for the year ended December 31, 2024, was driven by OXICLEAN® stain removers, THERABREATH® mouth wash, ULTRAMAX® antiperspirant deodorant, and VITAFUSION® and L’IL CRITTERS® gummy vitamins in GMG, HERO® acne treatment products in Europe, HERO® acne treatment products in Canada, and THERABREATH® mouth wash in Mexico. 

Consumer International income from operations was $83.1 in 2024, a decrease of $21.1 compared to 2023 due to the VMS non-cash intangible and PP&E impairment charges of $29.7.  Excluding the non-cash impairment charges, Consumer International income from operations increased $8.6 and was driven by favorable price/mix of $36.2, higher sales volumes of $27.1, partially offset by higher marketing expenses of $29.2, higher SG&A expenses of $21.2 from growth investments, unfavorable foreign exchange rates of $3.4 and higher manufacturing and commodity costs of $0.6.

46

CHURCH & DWIGHT CO., INC AND SUBSIDIARIES(Dollars in millions, except share and per share data) 

Specialty Products 

2024 compared to 2023

SPD net sales were $303.3 for 2024, a decrease of $17.7, or 5.5% compared to 2023.  The components of the net sales change are the following: 

    Net Sales - SPD
    December 31, 2024

    Product volumes sold
     
    4.0
    %

    Pricing/Product mix
     
    3.1
    %

    Exit of product lines (1)
     
    (12.6
    %)

    Net Sales decrease